Bard Associates reports 336,007 shares (7.5%) in INLX
Intellinetics Inc reports a Schedule 13G filing showing Bard Associates, Inc. beneficially owns 336,007 shares of Common Stock, representing 7.5%.
Rhea-AI Filing Summary
Intellinetics Inc reports a Schedule 13G filing showing Bard Associates, Inc. beneficially owns 336,007 shares of Common Stock, representing 7.5%.
The filing breaks down voting and dispositive power: 19,650 shares of sole voting and dispositive power and 316,357 shares of shared dispositive power. The filing is signed by Michael Demaray, President, dated 05/14/2026.
Positive
- None.
Negative
- None.
Insights
Bard Associates reports a non‑control stake of 336,007 shares (7.5%), disclosing voting and dispositive splits.
The filing lists 19,650 shares with sole voting/dispositive power and 316,357 shares with shared dispositive power. This indicates a significant passive stake without stated intent to influence control.
Watch subsequent filings for changes in reported percentages or statements of intent; timing of any disclosure is not included in the excerpt.
Key Figures
Key Terms
Schedule 13G regulatory
Beneficial ownership financial
Dispositive power regulatory
CUSIP technical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Bard Associates report in Intellinetics (INLX)?
When was the Schedule 13G for INLX signed and by whom?
What do the voting and dispositive power numbers mean in this filing?
What identifier and class of security are reported for INLX?
Is Bard Associates claiming control of Intellinetics in this filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.